Skip to content

Verification of the Effectiveness of VR Training Using the New STAI and Heart Rate Variability Analysis Focusing on Newly Assigned Child Welfare Support Workers

Verification of the Effectiveness of VR Training Using the New STAI and Heart Rate Variability Analysis: Focusing on Newly Assigned Child Welfare Support Workers - VR-STAI-HRV Training and Research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059031
Enrollment
11
Registered
2025-09-15
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No relevant disease (study involving healthy adults)

Interventions

Intervention Name: VR-Based Interview Training (for Child Welfare Support Workers) Intervention Period: 2 weeks Intervention Sessions/Frequency: Total of 3 sessions (1-2 sessions per week, completed
Dose: Standalone HMD (e.g., 6DoF, refresh rate 60-90Hz, display brightness at standard settings, no additional radiation exposure) Controller or hand-tracking operation Heart rate variability
= 250 Hz recommended) Assessment Timepoints: STAI (State-Trait Anxiety Inventory): baseline (pre-intervention), immediately after each session (primary outcome at final session), and 1-month fol
rest for 10-15 minutes, if not improved discontinue the session Discontinue if HR increases abruptly compared to baseline (e.g., +40 bpm or more) with symptoms Postpone session in case of illnes

Sponsors

Tokyo City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Population: Newly assigned child guidance/support workers at child guidance centers or equivalent agencies 2. Time since assignment: Within 12 months at enrollment 3. Age: 20 years or older 4. Employment: Employed on a continuous basis (full-time or part-time) 5. Language: Able to understand and respond in Japanese 6. Availability: Able to attend all intervention sessions (e.g., 3 sessions over 2 weeks) and the 1-month follow-up 7. Assessments: Willing and able to complete STAI and HRV measurements (HR, HF, LF/HF) with ECG or chest belt device 8. Device tolerance: No impediment to wearing or using a VR HMD 9. Consent: Provides written informed consent after receiving study explanations

Exclusion criteria

Exclusion criteria: 1. Physical conditions Severe cardiovascular disease, arrhythmia, epilepsy, or severe respiratory illness that may interfere with VR training or HRV measurement Severe uncorrected visual or auditory impairment preventing the use of VR materials 2. VR-related limitations History of severe VR sickness or motion sickness making continuation of training difficult Head/neck disorders preventing safe use of head-mounted display (HMD) 3. Mental health conditions Acute phase of psychiatric disorder where participation may worsen symptoms Deemed inappropriate for participation by the investigator for safety or study validity reasons 4. Pregnancy / health status Pregnant women with severe morning sickness or unstable health condition Acute illness (fever, fatigue) on the day of training preventing safe participation 5. Participation conditions Unable or unwilling to provide written informed consent Unable to attend all scheduled intervention sessions or follow-up

Design outcomes

Primary

MeasureTime frame
Changes in State Anxiety and Trait Anxiety Scores Using the New STAI Version

Secondary

MeasureTime frame
Changes in Autonomic Nervous System Activity via Heart Rate Variability Analysis (HR, LF/HF, HF)

Countries

Japan

Contacts

Public Contactmiyagawa tetsuya

Tokyo City University Department of Human Sciences, Faculty of Human Sciences

dogtown0309@gmail.com0357070104

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026